( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)
Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

50 publications found

Warning: limit reached; process these papers and then reload to see if there are more for this author name string
Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Matched potential author: Chong Zhao - author of 1 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases[1]Chong Zhao, [2]Xin Chen, [3]Changshan Yang, [4]Dan Zang, [5]Xiaoying Lan, [6]Siyan Liao, [7]Peiquan Zhang, [8]Jinjie Wu, [9]Xiaofen Li, [10]Ningning Liu, [11]Yuning Liao, [12]Hongbiao Huang, [13]Xianping Shi, [14]Lili Jiang, [15]Xiuhua Liu, [16]Q Ping Dou, [17]Xuejun Wang, [18]Jinbao Liu [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.14572 [ORCID]
PubMed: 28086217 [ORCID]
2017-02-01Chong Zhao (Q89816212; 1 items)
Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms[1]Xiaoying Lan, [2]Chong Zhao, [3]Xin Chen, [4]Peiquan Zhang, [5]Dan Zang, [6]Jinjie Wu, [7]Jinghong Chen, [8]Huidan Long, [9]Li Yang, [10]Hongbiao Huang, [11]Bing Z Carter, [12]Xuejun Wang, [13]Xianping Shi, [14]Jinbao Liu [Full author list]Journal of Hematology & Oncology [missing]DOI: 10.1186/S13045-016-0359-X [ORCID]
PubMed: 27884201 [ORCID]
nickel [missing]; imatinib [missing]; chronic myeloid leukemia [missing]2016-11-25Chong Zhao (Q89816212; 1 items)
Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy[1]Chong Zhao, [2]Xin Chen, [3]Dan Zang, [4]Xiaoying Lan, [5]Siyan Liao, [6]Changshan Yang, [7]Peiquan Zhang, [8]Jinjie Wu, [9]Xiaofen Li, [10]Ningning Liu, [11]Yuning Liao, [12]Hongbiao Huang, [13]Xianping Shi, [14]Lili Jiang, [15]Xiuhua Liu, [16]Zhimin He, [17]Xuejun Wang, [18]Jinbao Liu [Full author list]Biochemical Pharmacology [missing]DOI: 10.1016/J.BCP.2016.06.019 [ORCID]
PubMed: 27381943 [ORCID]
platinum [missing]; cisplatin [missing]2016-07-02Chong Zhao (Q89816212; 1 items)
A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment[1]Lili Jiang, [2]Dan Zang, [3]Songgang Yi, [4]Xiaofen Li, [5]Changshan Yang, [6]Xiaoxian Dong, [7]Chong Zhao, [8]Xiaoying Lan, [9]Xin Chen, [10]Shouting Liu, [11]Ningning Liu, [12]Hongbiao Huang, [13]Xianping Shi, [14]Xuejun Wang, [15]Jinbao Liu [Full author list]Scientific Reports [missing]DOI: 10.1038/SREP21565 [ORCID]
PubMed: 26898246 [ORCID]
2016-02-22Chong Zhao (Q89816212; 1 items)
Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo[1]Hongbiao Huang, [2]Yuning Liao, [3]Ningning Liu, [4]Xianliang Hua, [5]Jianyu Cai, [6]Changshan Yang, [7]Huidan Long, [8]Chong Zhao, [9]Xin Chen, [10]Xiaoying Lan, [11]Dan Zang, [12]Jinjie Wu, [13]Xiaofen Li, [14]Xianping Shi, [15]Xuejun Wang, [16]Jinbao Liu [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.6425 [ORCID]
PubMed: 26625200 [ORCID]
2015-11-28Chong Zhao (Q89816212; 1 items)
Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition[1]Xianping Shi, [2]Xiaoying Lan, [3]Xin Chen, [4]Chong Zhao, [5]Xiaofen Li, [6]Shouting Liu, [7]Hongbiao Huang, [8]Ningning Liu, [9]Dan Zang, [10]Yuning Liao, [11]Peiquan Zhang, [12]Xuejun Wang, [13]Jinbao Liu [Full author list]Scientific Reports [missing]DOI: 10.1038/SREP09694 [ORCID]
PubMed: 25853502 [ORCID]
diffuse large B-cell lymphoma [missing]; B-cell lymphoma [missing]; gambogic acid [missing]2015-04-08Chong Zhao (Q89816212; 1 items)
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms[1]Xin Chen, [2]Xianping Shi, [3]Chong Zhao, [4]Xiaofen Li, [5]Xiaoying Lan, [6]Shouting Liu, [7]Hongbiao Huang, [8]Ningning Liu, [9]Siyan Liao, [10]Dan Zang, [11]Wenbin Song, [12]Quentin Liu, [13]Bing Z Carter, [14]Q Ping Dou, [15]Xuejun Wang, [16]Jinbao Liu [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.2361 [ORCID]
PubMed: 25193854 [ORCID]
leukemia [missing]; imatinib [missing]; chronic myeloid leukemia [missing]2014-10-01Chong Zhao (Q89816212; 1 items)
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth[1]Ningning Liu, [2]Xiaofen Li, [3]Hongbiao Huang, [4]Chong Zhao, [5]Siyan Liao, [6]Changshan Yang, [7]Shouting Liu, [8]Wenbin Song, [9]Xiaoyu Lu, [10]Xiaoying Lan, ... [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.2113 [ORCID]
PubMed: 24977961 [ORCID]
2014-07-01Chong Zhao (Q89816212; 1 items)
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases[1]Ningning Liu, [2]Chunjiao Liu, [3]Xiaofen Li, [4]Siyan Liao, [5]Wenbin Song, [6]Changshan Yang, [7]Chong Zhao, [8]Hongbiao Huang, [9]Lixia Guan, [10]Peiquan Zhang, [11]Shouting Liu, [12]Xianliang Hua, [13]Xin Chen, [14]Ping Zhou, [15]Xiaoying Lan, [16]Songgang Yi, [17]Shunqing Wang, [18]Xuejun Wang, [19]Q Ping Dou, [20]Jinbao Liu [Full author list]Scientific Reports [missing]DOI: 10.1038/SREP05240 [ORCID]
PubMed: 24912524 [ORCID]
proteolysis [missing]2014-06-10Chong Zhao (Q89816212; 1 items)
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation[1]Xianping Shi, [2]Xin Chen, [3]Xiaofen Li, [4]Xiaoying Lan, [5]Chong Zhao, [6]Shouting Liu, [7]Hongbiao Huang, [8]Ningning Liu, [9]Siyan Liao, [10]Wenbin Song, [11]Ping Zhou, [12]Shunqing Wang, [13]Li Xu, [14]Xuejun Wang, [15]Q Ping Dou, [16]Jinbao Liu [Full author list]Clinical Cancer Research [missing]DOI: 10.1158/1078-0432.CCR-13-1063 [ORCID]
PubMed: 24334603 [ORCID]
leukemia [missing]; chronic myeloid leukemia [missing]; apoptotic process [missing]; gambogic acid [missing]2013-12-12Chong Zhao (Q89816212; 1 items)

Group #2

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment[1]Wenhua Liang, [2]Guanzhu Shen, [3]Yaxiong Zhang, [4]Gang Chen, [5]Xuan Wu, [6]Yang Li, [7]Anchuan Li, [8]Shiyang Kang, [9]Xi Yuan, [10]Xue Hou, [11]Peiyu Huang, [12]Yan Huang, [13]Hongyun Zhao, [14]Ying Tian, [15]Chong Zhao, [16]Li Zhang [Full author list]Chinese Journal of Cancer [missing]DOI: 10.1186/S40880-016-0160-9 [ORCID]
PubMed: 27887636 [ORCID]
2016-11-25
Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma[1]Ying Guan, [2]Shuai Liu, [3]Han-Yu Wang, [4]Ying Guo, [5]Weiwei Xiao, [6]Chun-Yan Chen, [7]Chong Zhao, [8]Tai-Xiang Lu, [9]Fei Han [Full author list]Chinese Journal of Cancer [missing]DOI: 10.1186/S40880-016-0081-7 [ORCID]
PubMed: 26879049 [ORCID]
cisplatin [missing]; phase II clinical trial [missing]2016-02-15
Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma[1]Meng-Xia Zhang, [2]Yi-Jun Hua, [3]Hai-Yun Wang, [4]Ling Zhou, [5]Hai-Qiang Mai, [6]Xiang Guo, [7]Chong Zhao, [8]Wen-Lin Huang, [9]Ming-Huang Hong, [10]Ming-Yuan Chen [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.7116 [ORCID]
PubMed: 26848773 [ORCID]
2016-02-01
Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study[1]Wen-Ze Qiu, [2]Pei-Yu Huang, [3]Jun-Li Shi, [4]Hai-Qun Xia, [5]Chong Zhao, [6]Ka-Jia Cao [Full author list]Chinese Journal of Cancer [missing]DOI: 10.1186/S40880-015-0076-9 [ORCID]
PubMed: 26739148 [ORCID]
Adaptive radiation therapy [missing]; chemotherapy [missing]; chemoradiotherapy [missing]2016-01-06
The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma[1]Ying Guan, [2]Anchuan Li, [3]Weiwei Xiao, [4]Shuai Liu, [5]Binbin Chen, [6]Taixiang Lu, [7]Chong Zhao, [8]Fei Han [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.5271 [ORCID]
PubMed: 26418895 [ORCID]
chemoradiotherapy [missing]2015-10-01
Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy[1]An-Chuan Li, [2]Weiwei Xiao, [3]Guan-Zhu Shen, [4]Lin Wang, [5]An-An Xu, [6]Yan-Qing Cao, [7]Shao-Min Huang, [8]Cheng-Guang Lin, [9]Fei Han, [10]Xiao-Wu Deng, [11]Chong Zhao [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.4312 [ORCID]
PubMed: 26087194 [ORCID]
chemotherapy [missing]2015-05-28
Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy[1]Weiwei Xiao, [2]Shuai Liu, [3]YunMing Tian, [4]Ying Guan, [5]ShaoMin Huang, [6]ChengGuang Lin, [7]Chong Zhao, [8]TaiXiang Lu, [9]Fei Han [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0125351 [ORCID]
PubMed: 25927527 [ORCID]
2015-04-30
Activating enhancer-binding protein-2α induces cyclooxygenase-2 expression and promotes nasopharyngeal carcinoma growth[1]Dingbo Shi, [2]Xiangsheng Xiao, [3]Yun Tian, [4]Lijun Qin, [5]Fangyun Xie, [6]Rui Sun, [7]Jingshu Wang, [8]Wenbin Li, [9]Tianze Liu, [10]Yao Xiao, [11]Wendan Yu, [12]Wei Guo, [13]Yuqing Xiong, [14]Huijuan Qiu, [15]Tiebang Kang, [16]Wenlin Huang, [17]Chong Zhao, [18]Wuguo Deng [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.3215 [ORCID]
PubMed: 25669978 [ORCID]
2015-03-01
Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy[1]YingJie Zheng, [2]Fei Han, [3]Weiwei Xiao, [4]YanQun Xiang, [5]LiXia Lu, [6]XiaoWu Deng, [7]NianJi Cui, [8]Chong Zhao [Full author list]Radiation Oncology [missing]DOI: 10.1186/S13014-014-0326-Z [ORCID]
PubMed: 25582731 [ORCID]
Adaptive radiation therapy [missing]2015-01-13
Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis[1]Ming-Yuan Chen, [2]Hai-Qiang Mai, [3]Rui Sun, [4]Xiang Guo, [5]Chong Zhao, [6]Ming-Huang Hong, [7]Yi-Jun Hua [Full author list]Chinese Journal of Cancer [missing]DOI: 10.5732/CJC.012.10252 [ORCID]
PubMed: 23816556 [ORCID]
2013-07-02
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy[1]Huai Liu, [2]Bin Qi, [3]Xiang Guo, [4]Lin-Quan Tang, [5]Qiu-Yan Chen, [6]Lu Zhang, [7]Ling Guo, [8]Dong-Hua Luo, [9]Pei-Yu Huang, [10]Hao-Yuan Mo, ..., [17]Xing Lv, [18]Lin Wang, [19]Chong Zhao, [20]Ka-Jia Cao, [21]Chao-Nan Qian, ... [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0082750 [ORCID]
PubMed: 24340057 [ORCID]
chemotherapy [missing]; chemoradiotherapy [missing]2013-01-01
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy[1]Sheng-Fa Su, [2]Fei Han, [3]Chong Zhao, [4]Ying Huang, [5]Chun-Yan Chen, [6]Wei-Wei Xiao, [7]Jia-Xin Li, [8]Tai-Xiang Lu [Full author list]Chinese Journal of Cancer [missing]DOI: 10.5732/CJC.010.10547 [ORCID]
PubMed: 21801605 [ORCID]
Adaptive radiation therapy [missing]; patient [missing]2011-08-01
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials[1]Li Zhang, [2]Chong Zhao, [3]Bijesh Ghimire, [4]Ming-Huang Hong, [5]Qing Liu, [6]Yang Zhang, [7]Ying Guo, [8]Yi-Jun Huang, [9]Zhong-Zhen Guan [Full author list]BMC Cancer [missing]DOI: 10.1186/1471-2407-10-558 [ORCID]
PubMed: 20950416 [ORCID]
meta-analysis [missing]; chemoradiotherapy [missing]; phase III clinical trial [missing]2010-10-15
Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma[1]Shao-Xiong Wu, [2]Daniel T T Chua, [3]Mei-Ling Deng, [4]Chong Zhao, [5]Feng-Yan Li, [6]Jonathan S T Sham, [7]Han-Yu Wang, [8]Yong Bao, [9]Yuan-Hong Gao, [10]Zhi-Fan Zeng [Full author list]International Journal of Radiation Oncology Biology Physics [missing]DOI: 10.1016/J.IJROBP.2007.03.037 [ORCID]
PubMed: 17601682 [ORCID]
Adaptive radiation therapy [missing]2007-07-02

Group #3

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study[1]Li-Ting Liu, [2]Qiu-Yan Chen, [3]Lin-Quan Tang, [4]Lu Zhang, [5]Shan-Shan Guo, [6]Ling Guo, [7]Hao-Yuan Mo, [8]Chong Zhao, [9]Xiang Guo, [10]Ming-Yuan Chen, [11]Chao-Nan Qian, [12]Mu-Sheng Zeng, [13]Ming-Huang Hong, [14]Jian-Yong Shao, [15]Ying Sun, [16]Jun Ma, [17]Hai-Qiang Mai [Full author list]BMC Cancer [missing]DOI: 10.1186/S12885-016-2803-2 [ORCID]
PubMed: 27717335 [ORCID]
2016-10-07
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study[1]Shan-Shan Guo, [2]Lin-Quan Tang, [3]Qiu-Yan Chen, [4]Lu Zhang, [5]Li-Ting Liu, [6]Ling Guo, [7]Hao-Yuan Mo, [8]Dong-Hua Luo, [9]Pei-Yu Huang, [10]Yan-Qun Xiang, ..., [13]Lin Wang, [14]Xing Lv, [15]Chong Zhao, [16]Xiang Guo, [17]Ka-Jia Cao, ... [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.8828 [ORCID]
PubMed: 27105538 [ORCID]
Epstein–Barr virus [missing]; chemotherapy [missing]; chemoradiotherapy [missing]2016-04-18
Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysis[1]Lu Zhang, [2]Huai Liu, [3]Lin-Quan Tang, [4]Qiu-Yan Chen, [5]Shan-Shan Guo, [6]Li-Ting Liu, [7]Ling Guo, [8]Hao-Yuan Mo, [9]Chong Zhao, [10]Xiang Guo, [11]Ka-Jia Cao, [12]Chao-Nan Qian, [13]Mu-Sheng Zeng, [14]Jian-Yong Shao, [15]Ying Sun, [16]Jun Ma, [17]Ming-Huang Hong, [18]Hai-Qiang Mai [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.8008 [ORCID]
PubMed: 26980734 [ORCID]
2016-04-01
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy[1]Lu Zhang, [2]Lin-Quan Tang, [3]Qiu-Yan Chen, [4]Huai Liu, [5]Shan-Shan Guo, [6]Li-Ting Liu, [7]Ling Guo, [8]Hao-Yuan Mo, [9]Chong Zhao, [10]Xiang Guo, [11]Ka-Jia Cao, [12]Chao-Nan Qian, [13]Mu-Sheng Zeng, [14]Jian-Yong Shao, [15]Ying Sun, [16]Jun Ma, [17]Ming-Huang Hong, [18]Hai-Qiang Mai [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.6754 [ORCID]
PubMed: 26716900 [ORCID]
Epstein–Barr virus [missing]2016-02-01
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy[1]Shan-Shan Guo, [2]Lin-Quan Tang, [3]Lu Zhang, [4]Qiu-Yan Chen, [5]Li-Ting Liu, [6]Ling Guo, [7]Hao-Yuan Mo, [8]Dong-Hua Luo, [9]Pei-Yu Huang, [10]Yan-Qun Xiang, ..., [13]Lin Wang, [14]Xing Lv, [15]Chong Zhao, [16]Xiang Guo, [17]Ka-Jia Cao, ... [Full author list]BMC Cancer [missing]DOI: 10.1186/S12885-015-1964-8 [ORCID]
PubMed: 26675209 [ORCID]
cisplatin [missing]; chemoradiotherapy [missing]2015-12-16
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma[1]Wen-Hui Chen, [2]Lin-Quan Tang, [3]Lu Zhang, [4]Qiu-Yan Chen, [5]Shan-Shan Guo, [6]Li-Ting Liu, [7]Wei Fan, [8]Xu Zhang, [9]Ling Guo, [10]Chong Zhao, [11]Ka-Jia Cao, [12]Chao-Nan Qian, [13]Xiang Guo, [14]Dan Xie, [15]Mu-Sheng Zeng, [16]Hai-Qiang Mai [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.5699 [ORCID]
PubMed: 26512922 [ORCID]
Epstein–Barr virus [missing]; positron emission tomography [missing]2015-11-01

Group #4

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
A randomized phase II study of low-dose decitabine versus low-dose azacitidine in lower risk MDS and MDS/MPN.[1]Elias Jabbour, [2]Nicholas J. Short, [3]Guillermo Montalban-Bravo, [4]Xuelin Huang, [5]Carlos B Bueso-Ramos, [6]Wei Qiao, [7]Hui Yang, [8]Chong Zhao, [9]Tapan Kadia, [10]Gautam Borthakur, ... [Full author list]Blood [missing]DOI: 10.1182/BLOOD-2017-06-788497 [ORCID]
PubMed: 28774880 [ORCID]
2017-08-03
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.[1]Rashmi Kanagal-shamanna, [2]Rajyalakshmi Luthra, [3]C Cameron Yin, [4]Keyur P Patel, [5]Koichi Takahashi, [6]Xinyan Lu, [7]John Lee, [8]Chong Zhao, [9]Francesco C. Stingo, [10]Zhuang Zuo, [11]Mark J Routbort, [12]Rajesh R Singh, [13]Patricia Fox, [14]Farhad Ravandi, [15]Guillermo Garcia-Manero, [16]L Jeffrey Medeiros, [17]Carlos B Bueso-Ramos [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.7350 [ORCID]
PubMed: 26883102 [ORCID]
2016-02-12

Group #5

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells[1]Yinhui Dong, [2]Shutao Yin, [3]Cheng Jiang, [4]Xiaohe Luo, [5]Xiao Guo, [6]Chong Zhao, [7]Lihong Fan, [8]Yubing Meng, [9]Junxuan Lü, [10]Xinhua Song, [11]Xudong Zhang, [12]Ni Chen, [13]Hongbo Hu [Full author list]Autophagy [missing]DOI: 10.4161/AUTO.27210 [ORCID]
PubMed: 24389959 [ORCID]
autophagy [missing]2013-12-18
Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells[1]Chong Zhao, [2]Shutao Yin, [3]Yinhui Dong, [4]Xiao Guo, [5]Lihong Fan, [6]Min Ye, [7]Hongbo Hu [Full author list]Autophagy [missing]DOI: 10.4161/AUTO.22805 [ORCID]
PubMed: 23182854 [ORCID]
autophagy [missing]2012-11-26

Group #6

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Effects of long-term elevated temperature on covering, sheltering and righting behaviors of the sea urchin Strongylocentrotus intermedius[1]Lisheng Zhang, [2]Lingling Zhang, [3]Dongtao Shi, [4]Jing Wei, [5]Yaqing Chang, [6]Chong Zhao [Full author list]PeerJ [missing]DOI: 10.7717/PEERJ.3122 [ORCID]
PubMed: 28348933 [ORCID]
Strongylocentrotus intermedius [missing]2017-03-22
Effects of light and covering behavior on PAX6 expression in the sea urchin Strongylocentrotus intermedius[1]Chong Zhao, [2]Nanjing Ji, [3]Ping Sun, [4]Wenping Feng, [5]Jing Wei, [6]Yaqing Chang [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0110895 [ORCID]
PubMed: 25333874 [ORCID]
Strongylocentrotus intermedius [missing]2014-10-21
Effects of covering behavior and exposure to a predatory crab Charybdis japonica on survival and HSP70 expression of juvenile sea urchins Strongylocentrotus intermedius[1]Chong Zhao, [2]Nanjing Ji, [3]Binglong Zhang, [4]Ping Sun, [5]Wenping Feng, [6]Jing Wei, [7]Yaqing Chang [Full author list]PLOS One [missing]DOI: 10.1371/JOURNAL.PONE.0097840 [ORCID]
PubMed: 24837036 [ORCID]
Asian paddle crab [missing]; Strongylocentrotus intermedius [missing]2014-05-16

Group #7

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer[1]Kristina R. Dahlstrom, [2]Guojun Li, [3]Caroline S Hussey, [4]Jenny T Vo, [5]Qingyi Wei, [6]Chong Zhao, [7]Erich M Sturgis [Full author list]Cancer [missing]DOI: 10.1002/CNCR.29538 [ORCID]
PubMed: 26094818 [ORCID]
2015-06-19
Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites[1]Xuemei Ji, [2]Erich M Sturgis, [3]Chong Zhao, [4]Carol J Etzel, [5]Qingyi Wei, [6]Guojun Li [Full author list]Cancer [missing]DOI: 10.1002/CNCR.24184 [ORCID]
PubMed: 19197996 [ORCID]
head and neck squamous cell carcinoma [missing]2009-04-01

Misc

Matched potential author: Chong Zhao - author of 6 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Silencing of FANCD2 enhances the radiosensitivity of metastatic cervical lymph node-derived head and neck squamous cell carcinoma HSC-4 cells[1]Hua-Jun Feng, [2]Yi-Lin Bao, [3]Zhuo-Ping Liang, [4]Fei-Peng Zhao, [5]Sheng-En Xu, [6]Wei Xu, [7]Chong Zhao, [8]Gang Qin [Full author list]International Journal of Oncology [missing]DOI: 10.3892/IJO.2017.3902 [ORCID]
PubMed: 28350060 [ORCID]
head and neck squamous cell carcinoma [missing]2017-03-07
Study on the Polarization of Random Lasers from Dye-Doped Nematic Liquid Crystals[1]Lihua Ye, [2]Chong Zhao, [3]Yangyang Feng, [4]Bing Gu, [5]Yiping Cui, [6]Yanqing Lu [Full author list]Nanoscale Research Letters [missing]DOI: 10.1186/S11671-016-1778-X [ORCID]
PubMed: 28078608 [ORCID]
2017-01-11
Controlling the magnetic properties of dysprosium metallofullerene within metal-organic frameworks[1]Yongjian Li, [2]Taishan Wang, [3]Haibing Meng, [4]Chong Zhao, [5]Mingzhe Nie, [6]Li Jiang, [7]Chunru Wang [Full author list]Dalton Transactions [missing]DOI: 10.1039/C6DT04180A [ORCID]
PubMed: 27885366 [ORCID]
dysprosium [missing]; Metal-organic framework [missing]2016-11-25Chong Zhao (Q89083800; 6 items)
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial[1]Li Zhang, [2]Yan Huang, [3]Shaodong Hong, [4]Yunpeng Yang, [5]Gengsheng Yu, [6]Jun Jia, [7]Peijian Peng, [8]Xuan Wu, [9]Qing Lin, [10]Xuping Xi, ..., [26]Yingni Lian, [27]Quanlie Yang, [28]Chong Zhao [Full author list]The Lancet [missing]DOI: 10.1016/S0140-6736(16)31388-5 [ORCID]
PubMed: 27567279 [ORCID]
fluorouracil [missing]; cisplatin [missing]; multicenter clinical trial [missing]; phase III clinical trial [missing]2016-08-23
Involvement of the NFX1-repressor complex in PKC-δ-induced repression of hTERT transcription[1]Shuntaro Yamashita, [2]Kaoru Fujii, [3]Chong Zhao, [4]Hiroshi Takagi, [5]Yoshinori Katakura [Full author list]Journal of Biochemistry [missing]DOI: 10.1093/JB/MVW038 [ORCID]
PubMed: 27311997 [ORCID]
2016-06-15
Unusual role of epilayer-substrate interactions in determining orientational relations in van der Waals epitaxy[1]Lei Liu, [2]David A Siegel, [3]Wei Chen, [4]Peizhi Liu, [5]Junjie Guo, [6]Gerd Duscher, [7]Chong Zhao, [8]Hao Wang, [9]Wenlong Wang, [10]Xuedong Bai, [11]Kevin F McCarty, [12]Zhenyu Zhang, [13]Gong Gu [Full author list]Proceedings of the National Academy of Sciences of the United States of America [missing]DOI: 10.1073/PNAS.1405613111 [ORCID]
PubMed: 25385622 [ORCID]
2014-11-10
Comprehensive treatment of squamous cell cancer of head and neck: Chinese expert consensus 2013[1]Jinyi Lang, [2]Li Gao, [3]Ye Guo, [4]Chong Zhao, [5]Chenping Zhang, [6]Society of Head & Neck Tumor Surgery, [7]Society of Radiation Therapy, [8]Chinese Anti-Cancer Association [Full author list]Future Oncology [missing]DOI: 10.2217/FON.14.44 [ORCID]
PubMed: 24635574 [ORCID]
2014-03-17
Expression of matrix metalloproteinase-12 in aortic dissection[1]Yi Song, [2]Yuehui Xie, [3]Feng Liu, [4]Chong Zhao, [5]Rui Yu, [6]Shao Ban, [7]Qiufang Ye, [8]Jianxion Wen, [9]Haibo Wan, [10]Xiang Li, [11]Runwei Ma, [12]Zhaohui Meng [Full author list]BMC Cardiovascular Disorders [missing]DOI: 10.1007/S15027-013-0021-2 [ORCID]
PubMed: 23642232 [ORCID]
2013-05-03
Optimal waveforms design for ultra-wideband impulse radio sensors[1]Bin Li, [2]Zheng Zhou, [3]Weixia Zou, [4]Dejian Li, [5]Chong Zhao [Full author list]Sensors [missing]DOI: 10.3390/S101211038 [ORCID]
PubMed: 22163511 [ORCID]
2010-12-06
Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons[1]Shengjun Chang, [2]Xiangning Jiang, [3]Chong Zhao, [4]Christina Lee, [5]Donna M Ferriero [Full author list]Neuroscience Letters [missing]DOI: 10.1016/J.NEULET.2008.06.005 [ORCID]
PubMed: 18597936 [ORCID]
2008-06-07
Structure and Ca2+ regulation of frog photoreceptor guanylate cyclase, ROS-GC1.[1]Iswari Subbaraya, [2]Chong Zhao, [3]Teresa Duda [Full author list]Molecular and Cellular Biochemistry [missing]DOI: 10.1023/A:1027311811807 [ORCID]
PubMed: 14674678 [ORCID]
photoreceptor protein [missing]2003-12-01

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Chong Zhaoresearcher (ORCID 0000-0001-8816-5915)6ORCID: 0000-0001-8816-5915
Guizhou Medical University [missing]
Institute of Chemistry [missing]
Chong Zhaoresearcher (ORCID 0000-0002-9941-8049)1ORCID: 0000-0002-9941-8049
Chong Zhaoresearcher ORCID 0000-0003-2168-81501ORCID: 0000-0003-2168-8150
Chong Zhaoperson, CBDB = 1558270
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Chong Zhao | Author has ORCID ID:
Check VIAF for Chong Zhao | Author has VIAF ID:
Check ResearchGate for Chong Zhao | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers

Feedback
Source and documentation (at github)
Wikidata page